
SR-717
CAS No. 2375421-09-1
SR-717( —— )
Catalog No. M22380 CAS No. 2375421-09-1
SR-717 is a non-nucleotide STING agonist with EC50s of 2.1 μM and 2.2 μM in ISG-THP1 (WT) and ISG-THP1 cGAS KO (cGAS KO) cell lines, respectively.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
2MG | 68 | In Stock |
![]() ![]() |
5MG | 112 | In Stock |
![]() ![]() |
10MG | 177 | In Stock |
![]() ![]() |
25MG | 337 | In Stock |
![]() ![]() |
50MG | 487 | In Stock |
![]() ![]() |
100MG | 647 | In Stock |
![]() ![]() |
200MG | Get Quote | In Stock |
![]() ![]() |
500MG | Get Quote | In Stock |
![]() ![]() |
1G | Get Quote | In Stock |
![]() ![]() |
Biological Information
-
Product NameSR-717
-
NoteResearch use only, not for human use.
-
Brief DescriptionSR-717 is a non-nucleotide STING agonist with EC50s of 2.1 μM and 2.2 μM in ISG-THP1 (WT) and ISG-THP1 cGAS KO (cGAS KO) cell lines, respectively.
-
DescriptionSR-717 is a non-nucleotide STING agonist with EC50s of 2.1 μM and 2.2 μM in ISG-THP1 (WT) and ISG-THP1 cGAS KO (cGAS KO) cell lines, respectively. Antitumor activity.SR-717 displayed antitumor activity;?promoted the activation of CD8+ T, natural killer, and dendritic cells in relevant tissues;?and facilitated antigen cross-priming.?SR-717 also induced the expression of clinically relevant targets, including programmed cell death 1 ligand 1 (PD-L1), in a STING-dependent manner.
-
In Vitro——
-
In VivoAnimal Model:WT or Stinggt/gt mice Dosage:30 mg/kg Administration:Intraperitoneally; once-per-day for 1 week Result:Maximally inhibited tumor growth.
-
Synonyms——
-
PathwayImmunology/Inflammation
-
TargetSTING
-
RecptorSTING
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2375421-09-1
-
Formula Weight351.19
-
Molecular FormulaC15H8F2LiN5O3
-
Purity>98% (HPLC)
-
SolubilityDMSO:14.29 mg/mL (40.69 mM; Need ultrasonic)
-
SMILES[Li+].[O-]C(=O)c1cc(F)c(F)cc1NC(=O)c1ccc(nn1)-n1ccnc1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Chin E N , Yu C , Vartabedian V F , et al. Antitumor activity of a systemic STING-activating non-nucleotide cGAMP mimetic[J]. ence, 2020, 369(6506):993-999.
molnova catalog



related products
-
SR-717
SR-717 is a non-nucleotide STING agonist with EC50s of 2.1 μM and 2.2 μM in ISG-THP1 (WT) and ISG-THP1 cGAS KO (cGAS KO) cell lines, respectively.
-
diABZI STING agonist...
diABZI STING agonist-1 is a selective and potent interferon gene-stimulating receptor (STING) agonist with potential antitumor and anti-inflammatory activity for the study of cancer.
-
diABZI-C2-NH2
diABZI-C2-NH2 is an agonist of the interferon gene STING that modulates STING-dependent type I interferon production and can be used to study STING-mediated diseases.